Switchpoint Bio raises $5.3M in a pre-seed financing round to advance precision epigenomic profiling and AI for drug development, including a $5M investment from Treehouse Delmar Investments.
Amount Raised
$5.3 Million
Round Type
Pre-Seed
Investors
Description
Helsinki-Cambridge biotech startup Switchpoint Bio has emerged from stealth with $5.3 million raised in a pre-seed financing round. The funding includes a significant $5 million investment from Treehouse Delmar Investments. The company aims to provide drug developers with insights into patient treatment responses by monitoring biological changes through blood samples. By combining epigenomic profiling and AI, Switchpoint Bio will enhance understanding of how diseases and treatments affect human biology.
Quick answer
Switchpoint Bio raised $5.3 Million in a Pre-Seed round, dated November 11, 2026. Investors: Treehouse Delmar Investments.
- How much did Switchpoint Bio raise?
- Switchpoint Bio raised $5.3 Million in a Pre-Seed round on November 11, 2026.
- Who invested in Switchpoint Bio?
- Treehouse Delmar Investments is named as investors in this round.
- What does Switchpoint Bio do?
- Switchpoint Bio is a Helsinki-Cambridge biotech startup focused on improving drug development by utilizing precision epigenomic profiling and AI to analyze how patients respond to treatments.
- Who are the decision-makers at Switchpoint Bio?
- Fundz holds 2 contacts at Switchpoint Bio, including the Chief Technology Officer, Co-Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Switchpoint Bio that raised within 45 days of this round, from Fundz verified event records.
- Alterra Labs raised $13M (Seed) on November 10, 2026.
- Mosaic Intelligence Labs raised $47M (Seed) on November 10, 2026.
- Vale Biolabs raised $183K (Pre-Seed) on November 9, 2026.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- ABA Life raised $40M on October 30, 2026.
- Happy Health raised $75M on October 29, 2026.
Who to call at Switchpoint Bio, and when
A new round usually means Switchpoint Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Switchpoint Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Switchpoint Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Switchpoint Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Switchpoint Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Switchpoint Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.